23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether your intestines carry the right kind of bacteria for healthy digestion but has since expanded to include over 250,000 samples for everything […]
View More uBiome is jumping into therapeutics with a healthy $83 million in Series C financingCategory: ubiome
8VC has closed its second early-stage fund, seemingly with an eye on logistics and biotech
8VC, the early-stage, San Francisco-based venture firm founded in 2015 by serial entrepreneur Joe Lonsdale and four other general partners, has closed it second early-stage venture fund with $640 million in commitments, says one of its investors. The fund comes roughly two years after the firm closed its debut fund with $425 million, along with a […]
View More 8VC has closed its second early-stage fund, seemingly with an eye on logistics and biotechuBiome launches an at-home women’s health test for HPV, STI’s and bacterial vaginosis
SmartJane is a new women’s health test out from uBiome today that promises to check for 23 vaginal flora as well as 11 strains of the human papilloma virus and a string of sexually transmitted diseases like Chlamydia and gonorrhea from the comfort of your own home.
uBiome, which launched in 2012 to sequence and study the human microbiome, is best known for its at-home gut health test… Read More